Severe acute malnutrition and infection

Paediatrics and International Child Health

Volumn 34, Issue , 2014, Pages S1-S29

  Jones, Kelsey D J ^a,b   Berkley, James A ^a,c  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibiotics; Children; Diarrhoea; HIV; Infection; Malaria; Malnutrition; Measles; Pneumonia; Sepsis; Tuberculosis; Urinary tract infection

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC AGENT; ANTIRETROVIRUS AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CEFDINIR; CEFTRIAXONE; COTRIMOXAZOLE; DIHYDROARTEMISININ PLUS PIPERAQUINE; FLUCONAZOLE; GENTAMICIN; INFUSION FLUID; ISONIAZID; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; METRONIDAZOLE; NITAZOXANIDE; ORAL REHYDRATION SOLUTION; PARACETAMOL; PLACEBO; PYRIDOXINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; RETINOL; UNINDEXED DRUG; ZINC;

ACUTE DIARRHEA; ANOREXIA; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD NUTRITION; CRYPTOSPORIDIOSIS; DIARRHEA; DIET SUPPLEMENTATION; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSLIPIDEMIA; ESOPHAGUS CANDIDIASIS; EVIDENCE BASED PRACTICE; FEVER; GIARDIASIS; HEARING IMPAIRMENT; HEART DISEASE; HELMINTH; HELMINTHIASIS; HIV TEST; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRATION; INFECTION; INSULIN RESISTANCE; INTERFERON GAMMA RELEASE ASSAY; LACTIC ACIDOSIS; LIPODYSTROPHY; LIVER INJURY; LIVER TOXICITY; MALARIA; MALNUTRITION; MEASLES; MEASLES VACCINATION; MORTALITY; NAUSEA; NONHUMAN; NUTRIENT; OSTEOPENIA; OUTPATIENT CARE; PNEUMONIA; POINT OF CARE TESTING; POLYNEUROPATHY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHYDRATION; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SEVERE ACUTE MALNUTRITION; SINGLE DRUG DOSE; SKIN INFECTION; TASTE DISORDER; TUBERCULIN TEST; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; VERNER MORRISON SYNDROME; ADOLESCENT; CHILD; COMMUNICABLE DISEASES; COMPLICATION; INFANT; MEDICAL RESEARCH; PATHOLOGY; PRESCHOOL CHILD; TRENDS;

ADOLESCENT; BIOMEDICAL RESEARCH; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; HUMANS; INFANT; MALNUTRITION;

EID: 84919619129     PISSN: 20469047     EISSN: 20469055     Source Type: Journal    
DOI: 10.1179/2046904714Z.000000000218     Document Type: Article

References (204)

1. Black RE, Allen LH, Bhutta ZA, et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet. 2008;371(9608):243–260.
2. WHO, UNICEF, WFP, UN System Standing Committee on Nutrition. Joint Statement on the Community-Based Management of Severe Acute Malnutrition. 2007. http://www.who.int/maternal_child_adolescent/documents/a91065/en/
3. Alcoba G, Kerac M, Breysse S, Salpeteur C, Galetto-Lacour A, Briend A, Gervaix A. Do children with uncomplicated severe acute malnutrition need antibiotics? A systematic review and meta-analysis. PLoS One. 2013;8(1):e53184
4. Trehan I, Goldbach HS, LaGrone LN, Meuli GJ, Wang RJ, Maleta KM, Manary MJ. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med. 2013;368(5):425–35.
5. Woerther PL, Angebault C, Jacquier H, et al. Massive increase, spread, and exchange of extended spectrum beta-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin Infect Dis. 2011;53(7):677–685.
6. WHO. Pocket book of hospital care for children. 2005. http://www.who.int/maternal_child_adolescent/documents/9241546700/ en/
7. Ghoshal U, Ghoshal UC, Ranjan P, Naik SR, Ayyagari A. Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol. 2003;3:9.
8. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130(2 Suppl 1):S78-90.
9. Bolme P, Eriksson M, Paalzow L, Stintzing G, Zerihun G, Woldemariam T. Malnutrition and pharmacokinetics of penicillin in Ethiopian children. Pharmacol Toxicol. 1995;76(4):259-262.
10. Zerihun G, Ashton M, Eriksson M. Oral absorption of amoxicillin in Ethiopian children with respiratory symptoms and different nutritional status. Acta Paediatr Scand. 1991;80(10):972-974.
11. Ciliberto MA, Sandige H, Ndekha MJ, et al. Comparison of home-based therapy with ready-to-use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. Am J Clin Nutr. 2005;81(4):864-870.
12. Collins S, Sadler K, Dent N, et al. Key issues in the success of community-based management of severe malnutrition. Food Nutr Bull. 2006;27(3 Suppl):S49-82.
13. Maitland K, Berkley JA, Shebbe M, Peshu N, English M, Newton CR. Children with severe malnutrition: can those at highest risk of death be identified with the WHO protocol? PLoS Med. 2006;3(12):e500.
14. Okomo UA, Garba D, Fombah AE, et al. Bacterial Isolates and Antibiotic Sensitivity among Gambian Children with Severe Acute Malnutrition. Int J Pediatr. 2011;2011:825123.
15. Babirekere-Iriso E, Musoke P, Kekitiinwa A. Bacteraemia in severely malnourished children in an HIV-endemic setting. Ann Trop Paediatr. 2006;26(4):319-328.
16. Abrha A, Abdissa A, Beyene G, Getahun G, Girma T. Bacteraemia among severely malnourished children in jimma university hospital, ethiopia. Ethiop J Health Sci. 2011;21(3):175-182.
17. Noorani N, Macharia WM, Oyatsi D, Revathi G. Bacterial isolates in severely malnourished children at Kenyatta National Hospital, Nairobi. East Afr Med J. 2005;82(7):343-348.
18. Thame M, Stephen C, Wilks R, Forrester TE. The appropriateness of the current antibiotic empiric therapy based on the bacteria isolated from severely malnourished Jamaican children. West Indian Med J. 2001;50(2):140-143.
19. Christie CD, Heikens GT, Golden MH. Coagulase-negative staphylococcal bacteremia in severely malnourished Jamaican children. Pediatr Infect Dis J. 1992;11(12):1030-1036.
20. Cheung GY, Otto M. Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children. Curr Opin Infect Dis. 2010;23(3):208-216.
21. Deen J, von Seidlein L, Andersen F, Elle N, White NJ, Lubell Y. Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis. 2012;12(6):480-487.
22. Lazzerini M, Tickell D. Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics. Bull WHO. 2011;89(8):594-607.
23. Reed RP, Wegerhoff FO, Rothberg AD. Bacteraemia in malnourished rural African children. Ann Trop Paediatr. 1996;16(1):61-68.
24. Thuo N, Ungphakorn W, Karisa J, et al. Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation. J Antimcrob Chemother. 2011;66(10):2336-2345.
25. Aiken AM, Mturi N, Njuguna P, et al. Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study. Lancet. 2011;378(9808):2021–2027.
26. Moisi JC, Gatakaa H, Berkley JA, et al. Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. Bull WHO. 2011;89(10):725–732, 732A.
27. Kerac M, Bunn J, Seal A, et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi. Lancet. 2009;374(9684):136-144.
28. Sullivan PB, Marsh MN, Phillips MB, et al. Prevalence and treatment of giardiasis in chronic diarrhoea and malnutrition. Arch Dis Child. 1991;66(3):304–306.
29. Ignatius R, Gahutu JB, Klotz C, et al. High prevalence of Giardia duodenalis Assemblage B infection and association with underweight in Rwandan children. PLoS Negl Trop Dis. 2012;6(6):e1677.
30. Goto R, Mascie-Taylor CG, Lunn PG. Impact of intestinal permeability, inflammation status and parasitic infections on infant growth faltering in rural Bangladesh. Br J Nutr. 2009;101(10):1509–1516.
31. Goto R, Mascie-Taylor CG, Lunn PG. Impact of anti-Giardia and anthelminthic treatment on infant growth and intestinal permeability in rural Bangladesh: a randomised double-blind controlled study. Trans R Soc Trop Med Hyg. 2009;103(5):520–529.
32. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978–2990.
33. Omoike IU, Abiodun PO. Upper small intestinal microflora in diarrhea and malnutrition in Nigerian children. J Pediatr Gastroenterol Nutr. 1989;9(3):314–321.
34. Heyworth B, Brown J. Jejunal microflora in malnourished Gambian children. Archives of disease in childhood. 1975;50(1):27–33.
35. Gracey MS. Nutrition, bacteria and the gut. Br Med Bull. 1981;37(1):71–75.
36. Trehan I, Shulman RJ, Ou CN, Maleta K, Manary MJ. A randomized, double-blind, placebo-controlled trial of rifax-imin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am J Gastroenterol. 2009;104(9):2326–2333.
37. Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol. 1999;94(5):1327–1331.
38. Sakaguchi S, Saito M, Tsuji H, et al. Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol. 2010;48(5):1624–1628.
39. Enwonwu CO, Falkler WA, Jr., Phillips RS. Noma (cancrum oris). Lancet. 2006;368(9530):147–156.
40. Sadjjadi SM, Alborzi AW, Mostovfi H. Comparative clinical trial of mebendazole and metronidazole in giardiasis of children. J Trop Pediatr. 2001;47(3):176–178.
41. Lares-Asseff I, Cravioto J, Santiago P, Perez-Ortiz B. A new dosing regimen for metronidazole in malnourished children. Scand J Infect Dis. 1993;25(1):115–121.
42. Liver Tox, Clinical and Research Information on Drug Induced Liver Injury. 2012. http://livertox.nih.gov/Metronidazole.htm
43. Kofoed PE, Ursing J, Rodrigues A, Rombo L. Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial. Malaria J. 2011;10:148.
44. Brandts CH, Ndjave M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. 1997;350(9079):704–709.
45. Mehta S, Nain CK, Yadav D, Sharma B, Mathur VS. Disposition of acetaminophen in children with protein calorie malnutrition. Int J Clin Pharmacol Ther Toxicol. 1985;23(6):311–315.
46. Chiappini E, Principi N, Longhi R, et al. Management of fever in children: summary of the Italian Pediatric Society guidelines. Clin Ther. 2009;31(8):1826–1843.
47. Russell FM, Shann F, Curtis N, Mulholland K. Evidence on the use of paracetamol in febrile children. Bull WHO. 2003;81(5):367–372.
48. Schaaf HS, Marais BJ, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis. 2007;7:140.
49. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis J. 2008;8(8):498–510.
50. Ling DI, Zwerling AA, Steingart KR, Pai M. Immune-based diagnostics for TB in children: what is the evidence? Paediatr Respir Rev. 2011;12(1):9–15.
51. Pearce EC, Woodward JF, Nyandiko WM, Vreeman RC, Ayaya SO. A systematic review of clinical diagnostic systems used in the diagnosis of tuberculosis in children. AIDS Res Treat. 2012;2012:401896.
52. WHO. Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2006. http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.371_eng.pdf
53. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev. 2008;66(10 Suppl 2):S153–164.
54. Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA. 2011;108(47):19013–19017.
55. Martineau AR, Wilkinson KA, Newton SM, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol. 2007;178(11):7190–7198.
56. Battersby AJ, Kampmann B, Burl S. Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol. 2012;2012:430972.
57. Smythe PM, Brereton-Stiles GG, Grace HJ, et al. Thymolymphatic deficiency and depression of cell-mediated immunity in protein-calorie malnutrition. Lancet. 1971;2(7731): 939–943.
58. Harland PS. Tuberculin reactions in malnourished children. Lancet. 1965;2(7415):719–721.
59. Thomas TA, Mondal D, Noor Z, et al. Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics. Dec 2010;126(6):e1522–1529.
60. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011;15(8):1018–1032.
61. Rose MV, Kimaro G, Nissen TN, et al. QuantiFERON(R)-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One. 2012;7(7):e37851.
62. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet. 2004;364(9452):2196–2203.
63. van der Watt JJ, Harrison TB, Benatar M, Heckmann JM. Polyneuropathy, anti-tuberculosis treatment and the role of pyridoxine in the HIV/AIDS era: a systematic review. Int J Tuberc Lung Dis. 2011;15(6):722–728.
64. Pellock JM, Howell J, Kendig EL, Jr., Baker H. Pyridoxine deficiency in children treated with isoniazid. Chest. 1985;87(5):658–661.
65. Cilliers K, Labadarios D, Schaaf HS, et al. Pyridoxal-5-phosphate plasma concentrations in children receiving tuberculosis chemotherapy including isoniazid. Acta Paediatr. 2010;99(5):705–710.
66. Hathcock JN. Vitamins and minerals: efficacy and safety. Am J Clin Nutr. 1997;66(2):427–437.
67. Heikens GT, Bunn J, Amadi B, et al. Case management of HIV-infected severely malnourished children: challenges in the area of highest prevalence. Lancet. 2008;371(9620):1305–1307.
68. Trehan I, O’Hare BA, Phiri A, Heikens GT. Challenges in the Management of HIV-Infected Malnourished Children in Sub-Saharan Africa. AIDS Res Treat. 2012;2012:790786.
69. Bahwere P, Piwoz E, Joshua MC, Sadler K, Grobler-Tanner CH, Guerrero S, Collins S. Uptake of HIV testing and outcomes within a Community-based Therapeutic Care (CTC) programme to treat severe acute malnutrition in Malawi: a descriptive study. BMC Infect Dis. 2008;8:106
70. WHO. Second Generation Surveillance for HIV/AIDS. http://www.who.int/hiv/topics/surveillance/2ndgen/en/
71. Madec Y, Germanaud D, Moya-Alvarez V, et al. HIV prevalence and impact on renutrition in children hospitalised for severe malnutrition in Niger: an argument for more systematic screening. PLoS One. 2011;6(7):e22787.
72. Fergusson P, Tomkins A. HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2009;103(6):541–548.
73. Karande S, Bhalke S, Kelkar A, Ahuja S, Kulkarni M, Mathur M. Utility of clinically-directed selective screening to diagnose HIV infection in hospitalized children in Bombay, India. J Trop Pediatr. 2002;48(3):149–155.
74. Taye B, Shiferaw S, Enquselassie F. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART). Ethiop Med J. 2010;48(1):1–10.
75. Savino W, Dardenne M, Velloso LA, Dayse Silva-Barbosa S. The thymus is a common target in malnutrition and infection. Br J Nutr. 2007;98Suppl 1:S11–16.
76. Hughes SM, Amadi B, Mwiya M, et al. CD4 counts decline despite nutritional recovery in HIV-infected Zambian children with severe malnutrition. Pediatrics. 2009;123(2):e347–351.
77. Bachou H, Tylleskar T, Downing R, Tumwine JK. Severe malnutrition with and without HIV-1 infection in hospitalized children in Kampala, Uganda: differences in clinical features, haematological findings and CD4z cell counts. Nutr J. 2006;5:27.
78. Sunguya BF, Poudel KC, Otsuka K, et al. Undernutrition among HIV-positive children in Dar es Salaam, Tanzania: antiretroviral therapy alone is not enough. BMC Public Health. 2011;11:869.
79. Prendergast AJ, Penazzato M, Cotton M, et al. Treatment of young children with HIV infection: using evidence to inform policymakers. PLoS Med. 2012;9(7):e1001273.
80. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):2233–2244.
81. Prendergast A, Bwakura-Dangarembizi MF, Cook AD, et al. Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy. AIDS. 2011;25(7): 951–956.
82. Wang ME, Castillo ME, Montano SM, Zunt JR. Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru. Pediatr Infect Dis J. 2009;28(10):900–903.
83. Kim MH, Cox C, Dave A, et al. Prompt initiation of ART With therapeutic food is associated with improved outcomes in HIV-infected Malawian children with malnutrition. J Acquir Immun Defic Syndr. 2012;59(2):173–176.
84. Pollock L, Else L, Poerksen G, et al. Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets. J Antimicrob Chemother. 2009;64(6):1251–1259.
85. Ellis JC, L’Homme R F, Ewings FM, et al. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia. Antivir Ther. 2007;12(2):253–260.
86. Swaminathan S, Ramachandran G, Agibothu Kupparam HK, et al. Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India. J Antimicrob Chemother. 2011;66(6):1354–9
87. Weigel R, Phiri S, Chiputula F, et al. Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi. Trop Med Int Health. 2010;15(8):934–944.
88. Aurpibul L, Puthanakit T, Taecharoenkul S, Sirisanthana T, Sirisanthana V. Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. AIDS Patient Care STDs. 2009;23(12):1067–1071.
89. Sutcliffe CG, van Dijk JH, Munsanje B, et al. Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infect Dis. 2011;11:54.
90. Bandyopadhyay A, Bhattacharyya S. Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy. Ann Trop Paediatr. 2008;28(4):279–285.
91. Musoke PM, Fergusson P. Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings. Am J Clin Nutr. 2011;94(6):1716S–1720S.
92. Mahlungulu S, Grobler LA, Visser ME, Volmink J. Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database Syst Rev. 2007(3):CD004536.
93. Irlam JH, Visser MM, Rollins NN, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev. 2010(12):CD003650.
94. Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364(9448):1865–1871.
95. Mukhopadhyay C, Wilson G, Pradhan D, Shivananda PG. Intestinal protozoal infestation profile in persistent diarrhea in children below age 5 years in western Nepal. Southeast Asian J Trop Med Public Health. 2007;38(1):13–19.
96. Wanachiwanawin D, Chokephaibulkit K, Lertlaituan P, Ongrotchanakun J, Chinabut P, Thakerngpol K. Intestinal microsporidiosis in HIV-infected children with diarrhea. Southeast Asian J Trop Med Public Health. 2002;33(2):241–245.
97. Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr. 2001;32(5):550–554.
98. Mor SM, Tzipori S. Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge. Clin Infect Dis. 2008;47(7):915–921.
99. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. Nov 2 2002;360(9343):1375–1380.
100. Maggi P, Larocca AM, Quarto M, et al. Effect of antiretroviral therapy on cryptosporidiosis and microspori-diosis in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis. 2000;19(3):213–217.
101. Carr A, Marriott D, Field A, Vasak E, Cooper DA. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet. Jan 24 1998;351(9098):256–261.
102. Foudraine NA, Weverling GJ, van Gool T, et al. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS. 1998;12(1):35–41.
103. Nyeko R, Kalyesubula I, Mworozi E, Bachou H. Lactose intolerance among severely malnourished children with diarrhoea admitted to the nutrition unit, Mulago hospital, Uganda. BMC Pediatr. 2010;10:31.
104. Nizami SQ, Bhutta ZA, Molla AM. Efficacy of traditional rice-lentil-yoghurt diet, lactose free milk protein-based formula and soy protein formula in management of secondary lactose intolerance with acute childhood diarrhoea. J Trop Pediatr. 1997;47(1):20–24.
105. Golden BE, Golden MH. Plasma zinc, rate of weight gain, and the energy cost of tissue deposition in children recovering from severe malnutrition on a cow’s milk or soya protein based diet. Am J Clin Nutr. 1981;34(5):892–899.
106. Godard C, Bustos M, Munoz M, Nussle D. Value of a chicken-based formula for refeeding of children with protracted diarrhea and malnutrition in a developing country. J Pediatr Gastroenterol Nutr. 1989;9(4):473–480.
107. Nurko S, Garcia-Aranda JA, Fishbein E, Perez-Zuniga MI. Successful use of a chicken-based diet for the treatment of severely malnourished children with persistent diarrhea: a prospective, randomized study. J Pediatr. 1997;131(3):405–412.
108. Amadi B, Mwiya M, Chomba E, et al. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition. J Trop Pediatr. 2005;51(1):5–10.
109. Marchisio P, Principi N. Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected]. Eur J Clin Microbiol Infect Dis. 1994;13(4):338–340.
110. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359(2):119–129.
111. Coovadia HM, Brown ER, Fowler MG, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;379(9812):221–228.
112. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362(24):2271–2281.
113. Kesho Bora Study Group, De Vincenzi I. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis. 2011;11(3):171–180.
114. Fox MP, Brooks D, Kuhn L, et al. Reduced mortality associated with breast-feeding-acquired HIV infection and breast-feeding among HIV-infected children in Zambia. J Acquir Immun Defic Syndr. 2008;48(1):90–96.
115. Alvarez-Uria G, Midde M, Pakam R, Bachu L, Naik PK. Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Study in India. ISRN Pediatr. 2012;2012:763591.
116. Becquet R, Bequet L, Ekouevi DK, et al. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Cote d’Ivoire. PLoS Med. 2007;4(1):e17.
117. Cartmell E, Natalal H, Francois I, Ferreira MH, Grahnquist L. Nutritional and clinical status of children admitted to the malnutrition ward, Maputo central hospital: a comparison of data from 2001 and 1983. J Trop Pediatr. 2005;51(2):102–105.
118. Berkley JA, Bejon P, Mwangi T, et al. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis. 2009;49(3):336–343.
119. von Seidlein L, Olaosebikan R, Hendriksen IC, et al. Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis. 2012;54(8):1080–1090.
120. Leslie T, Mikhail A, Mayan I, et al. Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study. Br Med J. 2012;345:e4389.
121. Kahama-Maro J, D’Acremont V, Mtasiwa D, Genton B, Lengeler C. Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam. Malaria J. 2011;10:332.
122. Gwer S, Newton CR, Berkley JA. Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg. 2007;77(6 Suppl):6–13.
123. Reyburn H, Mbakilwa H, Mwangi R, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. Br Med J. 2007;334(7590):403.
124. Graz B, Willcox M, Szeless T, Rougemont A. ‘Test and treat’ or presumptive treatment for malaria in high transmission situations? A reflection on the latest WHO guidelines. Malar J. 2011;10:136.
125. Murray CK, Gasser RA, Jr., Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev. 2008;21(1):97–110.
126. Abba K, Deeks JJ, Olliaro P, et al. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev. 2011(7):CD008122.
127. Verret WJ, Arinaitwe E, Wanzira H, et al. Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria. Antimicrob Agents Chemother. 2011;55(6):2629–2635.
128. Salako LA, Sowunmi A, Akinbami FO. Pharmacokinetics of quinine in African children suffering from kwashiorkor. Br J Clin Pharmacol. 1989;28(2):197–201.
129. Pussard E, Barennes H, Daouda H, et al. Quinine disposition in globally malnourished children with cerebral malaria. Clin Pharmacol Ther. 1999;65(5):500–510.
130. Treluyer JM, Roux A, Mugnier C, Flouvat B, Lagardere B. Metabolism of quinine in children with global malnutrition. Pediatr Res. 1996;40(4):558–563.
131. Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647–1657.
132. Wolday D, Kibreab T, Bukenya D, Hodes R. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyri-methamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire. Trans R Soc Trop Med Hyg. 1995;89(6):654–656.
133. Danquah I, Dietz E, Zanger P, et al. Reduced efficacy of intermittent preventive treatment of malaria in malnourished children. Antimicrob Agents Chemother. 2009;53(5):1753–1759.
134. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647–57
135. WHO. Guidelines for the treatment of malaria, second edition. 2010. http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html
136. Chisti MJ, Ahmed T, Faruque AS, Abdus Salam M. Clinical and laboratory features of radiologic pneumonia in severely malnourished infants attending an urban diarrhea treatment center in Bangladesh. Pediatr Infect Dis J. 2010;29(2):174–177.
137. Chisti MJ, Tebruegge M, La Vincente S, Graham SM, Duke T. Pneumonia in severely malnourished children in developing countries - mortality risk, aetiology and validity of WHO clinical signs: a systematic review. Trop Med Int Health. 2009;14(10):1173–1189.
138. Talbert A, Thuo N, Karisa J, et al. Diarrhoea complicating severe acute malnutrition in Kenyan children: a prospective descriptive study of risk factors and outcome. PLoS One. 2012;7(6):e38321.
139. Weisz A, Meuli G, Thakwalakwa C, Trehan I, Maleta K, Manary M. The duration of diarrhea and fever is associated with growth faltering in rural Malawian children aged 6–18 months. Nutr J. 2011;10(1):25.
140. Moore SR, Lima AA, Conaway MR, Schorling JB, Soares AM, Guerrant RL. Early childhood diarrhoea and hel-minthiases associate with long-term linear growth faltering. Int J Epidemiol. 2001;30(6):1457–1464.
141. Pringle K, Shah SP, Umulisa I, et al. Comparing the accuracy of the three popular clinical dehydration scales in children with diarrhea. Int J Emerg Med. 2011;4:58.
142. Alam NH, Islam S, Sattar S, Monira S, Desjeux JF. Safety of rapid intravenous rehydration and comparative efficacy of 3 oral rehydration solutions in the treatment of severely malnourished children with dehydrating cholera. J Pediatr Gastroenterol Nutr. 2009;48(3):318–327.
143. Mwangome MK, Fegan G, Prentice AM, Berkley JA. Are diagnostic criteria for acute malnutrition affected by hydration status in hospitalized children? A repeated measures study. Nutr J. 2011;10:92.
144. Golden MH. The development of concepts of malnutrition. J Nutr. Jul 2002;132(7):2117S–2122S.
145. Patrick J. Death during recovery from severe malnutrition and its possible relationship to sodium pump activity in the leucocyte. Br Med J. 1977;1(6068):1051–1054.
146. Schofield C, Ashworth A. Severe malnutrition in children: high case-fatality rates can be reduced. Africa Health. 1997;19(6):17–18.
147. Picot J, Hartwell D, Harris P, Mendes D, Clegg AJ, Takeda A. The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review. Health Technol Assess. 2012;16(19):1–316.
148. Alam NH, Hamadani JD, Dewan N, Fuchs GJ. Efficacy and safety of a modified oral rehydration solution (ReSoMaL) in the treatment of severely malnourished children with watery diarrhea. J Pediatr. 2003;143(5):614–619.
149. Dutta P, Mitra U, Manna B, et al. Double blind, randomised controlled clinical trial of hypo-osmolar oral rehydration salt solution in dehydrating acute diarrhoea in severely malnourished (marasmic) children. Arch Dis Child. 2001;84(3):237–240.
150. Alam S, Afzal K, Maheshwari M, Shukla I. Controlled trial of hypo-osmalar versus World Health Organization oral rehy-dration solution. Indian Pediatr. 2000;37(9):952–960.
151. Akech SO, Karisa J, Nakamya P, Boga M, Maitland K. Phase II trial of isotonic fluid resuscitation in Kenyan children with severe malnutrition and hypovolaemia. BMC Pediatr. 2010;10:71.
152. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364(26):2483–2495.
153. CDC. Recommendations for the use of antibiotics for the treatment of cholera. 2011. http://www.cdc.gov/cholera/treatment/antibiotic-treatment.html
154. Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2012;6:CD005436.
155. IZINCG. Developing Zinc Intervention Programmes. 2004. http://www.izincg.org/publications/files/IZiNCGTechDoc_FNB_ chapter3.pdf
156. Doherty CP, Sarkar MA, Shakur MS, Ling SC, Elton RA, Cutting WA. Zinc and rehabilitation from severe protein-energy malnutrition: higher-dose regimens are associated with increased mortality. Am J Clin Nutr. 1998;68(3):742–748.
157. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Cri Care Med. 2005;6(1):2–8.
158. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352(1):39–47.
159. Bachou H, Tumwine JK, Mwadime RK, Tylleskar T. Risk factors in hospital deaths in severely malnourished children in Kampala, Uganda. BMC pediatrics. 2006;6:7.
160. Bachou H, Tumwine JK, Mwadime RK, Ahmed T, Tylleskar T. Reduction of unnecessary transfusion and intravenous fluids in severely malnourished children is not enough to reduce mortality. Ann Trop Paediatr. 2008;28(1):23–33.
161. Faddan NH, Sayh KI, Shams H, Badrawy H. Myocardial dysfunction in malnourished children. Ann Pediatr Cardiol. 2010;3(2):113–118.
162. Gay NJ. The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis. 2004;189 Suppl 1: S27–35.
163. Simons E, Ferrari M, Fricks J, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012;379(9832):2173–2178.
164. Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153–164.
165. Pino-Lagos K, Guo Y, Brown C, et al. A retinoic acid-dependent checkpoint in the development of CD4z T cell-mediated immunity. J Exp Med. 2011;208(9):1767–1775.
166. Hall JA, Cannons JL, Grainger JR, et al. Essential role for retinoic acid in the promotion of CD4(z) T cell effector responses via retinoic acid receptor alpha. Immunity. 2011;34(3):435–447.
167. Benn CS. Combining vitamin A and vaccines: convenience or conflict? Danish Med J. 2012;59(1):B4378.
168. Yang HM MM, Wan C. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005, Issue 4. Art. No.: CD001479.
169. Coutsoudis A, Broughton M, Coovadia HM. Vitamin A supplementation reduces measles morbidity in young African children: a randomized, placebo-controlled, double-blind trial. Am J Clin Nutr. 1991;54(5):890–895.
170. Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med. 1990;323(3):160–164.
171. Barclay AJ, Foster A, Sommer A. Vitamin A supplements and mortality related to measles: a randomised clinical trial. Br Med J (Clin Res Ed). 1987;294(6567):294–296.
172. Donnen P, Sylla A, Dramaix M, Sall G, Kuakuvi N, Hennart P. Effect of daily low dose of vitamin A compared with single high dose on morbidity and mortality of hospitalized mainly malnourished children in senegal: a randomized controlled clinical trial. Eur J Clin Nutr. 2007;61(12):1393–1399.
173. Donnen P, Dramaix M, Brasseur D, Bitwe R, Vertongen F, Hennart P. Randomized placebo-controlled clinical trial of the effect of a single high dose or daily low doses of vitamin A on the morbidity of hospitalized, malnourished children. Am J Clin Nutr. 1998;68(6):1254–1260.
174. Ministry of Health Republic of Kenya. National Guideline for Integrated Management of Acute Malnutrition. 2009. Available at http://www.cmamforum.org/
175. Garly ML, Bale C, Martins CL, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. Br Med J. 2006;333(7581):1245.
176. Kabra SK, Lodha R, Hilton DJ. Antibiotics for preventing complications in children with measles. Cochrane Database Syst Rev. 2008(3):CD001477.
177. Powell GM. Response to live attenuated measles vaccine in children with severe kwashiorkor. Ann Trop Paediatr. 1982;2:143–5.
178. Savy M, Edmond K, Fine PE, et al. Landscape analysis of interactions between nutrition and vaccine responses in children. The Journal of nutrition. 2009;139(11):2154S–2218S.
179. Kurubi J, Vince J, Ripa P, Tefuarani N, Riddell M, Duke T. Immune response to measles vaccine in 6 month old infants in Papua New Guinea. Trop Med Int Health. Feb 2009;14(2):167–173.
180. Talley L, Salama P. Short report: assessing field vaccine efficacy for measles in famine-affected rural Ethiopia. Am J Trop Med Hyg. 2003;68(5):545–546.
181. Mahomva AI, Moyo IM, Mbengeranwa LO. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe. Cent Afr J Med. 1997;43(9):254–256.
182. WHO position on measles vaccines. Vaccine. 2009; 27(52):7219–7221.
183. Aaby P, Martins CL, Garly ML, Rodrigues A, Benn CS, Whittle H. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. Br Med J Open. 2012;2(4).
184. Williams GJ, Macaskill P, Chan SF, Turner RM, Hodson E, Craig JC. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis. 2010;10(4):240–250.
185. Bagga A, Tripathi P, Jatana V, et al. Bacteriuria and urinary tract infections in malnourished children. Pediatric nephrology. 2003;18(4):366-370.
186. Rabasa AI, Shattima D. Urinary tract infection in severely malnourished children at the University of Maiduguri Teaching Hospital. J Trop Pediatr. 2002;48(6):359-361.
187. Jeena PM, Coovadia HM, Adhikari M. A prospective study of bacteriuria and pyuria in catheter specimens from hospitalized children, Durban, South Africa. Ann Trop Paediatr. 1995;15(2):153–158.
188. Kala UK, Jacobs DW. Evaluation of urinary tract infection in malnourished black children. Ann Trop Paediatr. 1992;12(1):75–81.
189. Reed RP, Wegerhoff FO. Urinary tract infection in malnourished rural African children. Ann Trop Paediatr. 1995;15(1):21–26.
190. Thuo N, Ohuma E, Karisa J, Talbert A, Berkley JA, Maitland K. The prognostic value of dipstick urinalysis in children admitted to hospital with severe malnutrition. Arch Dis Child. 2010;95(6):422-426.
191. Caksen H, Cesur Y, Uner A, et al. Urinary tract infection and antibiotic susceptibility in malnourished children. Int J Urol Nephrol. 2000;32(2):245-247.
192. Shimeles D, Lulseged S. Clinical profile and pattern of infection in Ethiopian children with severe protein-energy malnutrition. East Afr Med J. 1994;71(4):264-267.
193. Campbell JA. The morbid anatomy of infantile malnutrition in Cape Town. Arch Dis Child. 1956;31(158):310-314.
194. Stirling GA. Renal pathology in malnourished infants. Arch Dis Child. 1962;37:378-382.
195. Isaack H, Mbise RL, Hirji KF. Nosocomial bacterial infections among children with severe protein energy malnutrition. East Afr Med J. 1992;69(8):433-436.
196. Russell BJ, White AV, Newbury J, Hattch C, Thurley J, Chang AB. Evaluation of hospitalisation for indigenous children with malnutrition living in central Australia. Aust J Rural Health. 2004;12(5):187–191.
197. Cotton MF, Berkowitz FE, Berkowitz Z, Becker PJ, Heney C. Nosocomial infections in black South African children. Pediatr Infect Dis J. 1989;8(10):676–683.
198. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367(9521):1521–1532.
199. Smith JL, Brooker S. Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review. Trop Med Int Health. Jul 2010;15(7):776–795.
200. Ziegelbauer K, Speich B, Mausezahl D, Bos R, Keiser J, Utzinger J. Effect of sanitation on soil-transmitted helminth infection: systematic review and meta-analysis. PLoS M\ed. 2012;9(1):e1001162.
201. Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008;299(16):1937–1948.
202. Steinmann P, Utzinger J, Du ZW, et al. Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial. PLoS One. 2011;6(9):e25003.
203. Granados CE, Reveiz L, Uribe LG, Criollo CP. Drugs for treating giardiasis. Cochrane Database Syst Rev. 2012;12:CD007787.
204. Rogers GL. Topical antimicrobial agents. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 3rd edn. Philadelphia, PA: Churchill Livingstone, 2008; pp 1519–27.